April 4, 2019
HepQuant’s Disease Severity Index (DSI) Demonstrates Hepatic Functional Improvement in High Percentage of NASH Patients Treated with Obeticholic Acid: Results from INTERCEPT 747-117
The First HepQuant SHUNT™ Data From An Interventional Drug Study in NASH DENVER–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/NASH?src=hash” target=”_blank”gt;#NASHlt;/agt;–HepQuant, LLC, a Greenwood Village,…